glp-1 glucose Glucagon-like peptide-1 π§π΅π² ππ³π³π²π°π πΌπ³ πππ£-π π₯π²π°π²π½ππΌπΏ
Description
The risk increases when GLP-1 drugs are combined with insulin or sulfonylureas, which is why dose adjustments are necessary in combination therapy
Patients should consider asking their doctor about fatty liver risk if they have obesity, excess abdominal weight, prediabetes, type 2 diabetes, high triglycerides, high blood pressure, sleep apnea, unexplained liver enzyme elevation, or liver fat found incidentally on ultrasound, CT scan, or MRI
Plant Foods Hum Nutr
Diet and Exercise Weight loss injections vs diet and exercise is a common debate
Who Should Consider Medical Weight Loss
